Stockreport

Catabasis Pharma's edasalonexent slows rate of functional decline in DMD boys in mid-stage study; shares ahead 29% premarket [Seeking Alpha]

Catabasis Pharmaceuticals, Inc.  (CATB) 
Last catabasis pharmaceuticals, inc. earnings: 3/10 08:05 am Check Earnings Report
US:NASDAQ Investor Relations: ir.catabasis.com/investor-overview
PDF Nano cap Catabasis Pharmaceuticals (NASDAQ: CATB ) is up   premarket on robust volume in response to the presentation of data from Part B of its Phase 2 clinica [Read more]